| 000 | 01564 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513232721.0 | ||
| 264 | 0 | _c20010426 | |
| 008 | 200104s 0 0 eng d | ||
| 022 | _a1524-4563 | ||
| 024 | 7 |
_a10.1161/01.hyp.37.2.806 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLaragh, J H | |
| 245 | 0 | 0 |
_aK(+) depletion and the progression of hypertensive disease or heart failure. The pathogenic role of diuretic-induced aldosterone secretion. _h[electronic resource] |
| 260 |
_bHypertension (Dallas, Tex. : 1979) _cFeb 2001 |
||
| 300 |
_a806-10 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
| 650 | 0 | 4 |
_aAldosterone _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBenzothiadiazines |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDiuretics |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 |
_aHypokalemia _xchemically induced |
| 650 | 0 | 4 |
_aMineralocorticoid Receptor Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aMuscles _xmetabolism |
| 650 | 0 | 4 |
_aPotassium _xblood |
| 650 | 0 | 4 |
_aSodium Chloride Symporter Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aSpironolactone _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSealey, J E | |
| 773 | 0 |
_tHypertension (Dallas, Tex. : 1979) _gvol. 37 _gno. 2 Pt 2 _gp. 806-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.hyp.37.2.806 _zAvailable from publisher's website |
| 999 |
_c11167883 _d11167883 |
||